Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial.

Source:http://linkedlifedata.com/resource/pubmed/id/16760174

Download in:

View as

General Info

PMID
16760174